# 8-K filed: Damora Therapeutics, Inc.

> sec 8k · VERIFIED · 2026-07-20

Filed: 2026-07-20 AccNo: 0001193125-26-308899 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

- Company: Damora Therapeutics, Inc.
- Primary source: https://www.sec.gov/Archives/edgar/data/1800315/000119312526308899/0001193125-26-308899-index.htm

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.